OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10369	Companies
216074	Keywords
145792	Articles
114416	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 08/04/2025 at 08:30, 9 months 4 days ago

Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten

Übernahme Partnerschaften Oxurion Axiodis CRO Klinische Daten
BRIEF

published on 07/30/2025 at 18:05, 9 months 8 days ago

Oxurion Réceptionne une Notification de Transparence Modifiée

Actions Transparence Atlas Special Opportunities Oxurion Bio-pharmaceutique
BRIEF

published on 07/30/2025 at 18:05, 9 months 8 days ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 9 months 8 days ago

Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding threshold

Transparency Notification Shareholding Belgium Oxurion NV Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/30/2025 at 18:00, 9 months 8 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement

Transparency Notification Biopharmaceutical Oxurion NV Voting Securities Shareholder Ownership
BRIEF

published on 07/25/2025 at 18:05, 9 months 13 days ago

Oxurion Annonce une Augmentation de Capital via Conversion d'Obligations

Augmentation De Capital Biopharmaceutique Actions Ordinaires Atlas Special Opportunities Oxurion
BRIEF

published on 07/25/2025 at 18:05, 9 months 13 days ago

Oxurion Announces Capital Increase via Bond Conversion

Common Shares Capital Increase Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/25/2025 at 18:00, 9 months 13 days ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 10 obligations convertibles en Oxurion, augmentant le capital de 250 000 EUR. Oxurion reçoit 11 161 618 nouvelles actions pour 250 000 EUR dans le cadre de l'engagement de 20 millions EUR d'Atlas

Innovation Capital Atlas Special Opportunities Oxurion Convertissement
PRESS RELEASE

published on 07/25/2025 at 18:00, 9 months 13 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation

Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/24/2025 at 18:05, 9 months 14 days ago

Augmentation du capital d'Oxurion suite à une conversion d'obligations

Capital Biotechnologie Actions Atlas Oxurion

Accesswire

Published on 05/08/2026 at 12:48, 43 minutes ago

Ur-Energy Reports Q1 2026 Results and Announces Conference Call and Webcast
Published on 05/08/2026 at 12:30, 1 hour 1 minute ago

Trans Canada Gold Completes Second Tranche of the Non-Brokered Private Placement and Prepares for Drilling at the Harrison Lake Gold Project
Published on 05/08/2026 at 10:30, 3 hours 1 minute ago

Previewing the Product Logic Behind Waton’s Next AI Trading Platform
Published on 05/08/2026 at 01:50, 11 hours 41 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 12 hours 46 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 13:05, 26 minutes ago

Philadelphia Soccer 2026 Opens Media Credentialing and Fan Registration for FIFA Fan Festival™ Philadelphia
Published on 05/08/2026 at 12:01, 1 hour 30 minutes ago

Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 05/08/2026 at 11:58, 1 hour 32 minutes ago

EQS-Adhoc: Aurubis AG: Aurubis AG raises 2025/26 full-year forecast based on improved market outlook
Published on 05/08/2026 at 11:45, 1 hour 46 minutes ago

MINISFORUM and Intel to Unveil a New Chapter of Agent NAS
Published on 05/08/2026 at 11:35, 1 hour 55 minutes ago

Cairn Homes Plc: Director Declaration

Les Echos

Published on 05/07/2026 at 19:15, 18 hours 16 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 18 hours 16 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 18 hours 25 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 18 hours 25 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 18 hours 31 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE